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Objectives: Traditionally, the urinary tract has been thought to be sterile in the absence
of a clinically identifiable infection. However, recent evidence suggests that the urinary
tract harbors a variety of bacterial species, known collectively as the urinary microbiome,
even when clinical cultures are negative. Whether these bacteria promote urinary health
or contribute to urinary tract disease remains unknown. Emerging evidence indicates
that a shift in the urinary microbiome may play an important role in urgency urinary
incontinence (UUI). The goal of this prospective pilot study was to determine how
the urinary microbiome is different between women with and without UUI. We also
sought to identify if characteristics of the urinary microbiome are associated with UUI
severity.
Methods: We collected urine from clinically well-characterized women with UUI (n = 10)
and normal bladder function (n = 10) using a transurethral catheter to avoid bacterial
contamination from external tissue. To characterize the resident microbial community,
we amplified the bacterial 16S rRNA gene by PCR and performed sequencing using
Illumina MiSeq. Sequences were processed using the workflow package QIIME. We
identified bacteria that had differential relative abundance between UUI and controls using
DESeq2 to fit generalized linear models based on the negative binomial distribution. We
also identified relationships between the diversity of the urinary microbiome and severity
of UUI symptoms with Pearson’s correlation coefficient.
Results: We successfully extracted and sequenced bacterial DNA from 95%
of the urine samples and identified that there is a polymicrobial community in
the female bladder in both healthy controls and women with UUI. We found
the relative abundance of 14 bacteria significantly differed between control and
UUI samples. Furthermore, we established that an increase in UUI symptom
severity is associated with a decrease in microbial diversity in women with UUI.
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Conclusions: Our study provides further characterization of the urinary microbiome
in both healthy controls and extensively phenotyped women with UUI. Our results also
suggest that the urinary microbiome may play an important role in the pathophysiology
of UUI and that the loss of microbial diversity may be associated with clinical severity.
Keywords: bladder disease, bladder microbiome, urinary microbiome, overactive bladder, human microbiome,
urinary incontinence, urge
INTRODUCTION
Nearly 19% of women over the age of 44 suffer from Urgency
Urinary Incontinence (UUI; Stewart et al., 2003)—a strong
sensation of the need to urinate (“urgency”) followed by
immediate leakage of a large volume of urine. The social,
psychological, and economic burden of this disorder are
enormous (Stewart et al., 2003; Norton and Brubaker, 2006;
Coyne et al., 2011). Fear of losing urinary control is associated
with depression, anxiety, social isolation, reduced functional
status, increased risk of institutionalization and overall negative
impact on quality of life (Coyne et al., 2013). The economic
burden of UUI is projected to be $82.6 billion by 2020 (Coyne
et al., 2014).
Despite the devastating impact of UUI, we have yet to fully
understand its underlying pathophysiology which is a significant
barrier to developing targeted interventions geared toward
eliminating or reducing symptoms. UUI is commonly attributed
to abnormal neuromuscular signaling causing involuntary
bladder muscle contractions known as detrusor overactivity
(DO). However, DO is only observed in approximately 58% of
women with UUI (Hashim and Abrams, 2006) and treatments
aimed at reducing DO are ineffective for approximately half
of the people that use them (Nitti et al., 2010). Even in those
with DO, it is unclear what underlying factors contribute to
this urodynamic observation. These findings suggest that more
attention needs to be placed on understanding pathophysiologic
mechanisms that contribute to UUI. Understanding these
mechanisms is a necessary step toward improving effectiveness
of existing therapy and introducing new therapeutic
approaches.
Emerging evidence indicates that a shift in the normal
microbiome of the bladder may play an important role in
pathophysiology of UUI. Currently, the diagnosis of UUI
requires exclusion of acute urinary tract infection (UTI), as there
is large overlap in symptomatology. Thus, standard of care rules
out an infectious etiology as a possible cause for UUI symptoms.
However, the long-held belief that urine is sterile in the absence
of an acute UTI has been recently challenged. New techniques
such as 16S rRNA gene sequencing (Nelson et al., 2010; Siddiqui
et al., 2011; Fouts et al., 2012;Wolfe et al., 2012; Lewis et al., 2013)
and expanded quantitative urine culture techniques (EQUC; Hilt
et al., 2014; Pearce et al., 2014) have revealed that urine samples
actually contain a variety of bacteria, many of which are not
detectable by standard culturing techniques. The use of 16S rRNA
gene sequencing and EQUC techniques have allowed researchers
to identify bacteria that are uncultivable under standard culture
conditions, and have identified a polymicrobial community of
bacteria that reside in the urinary tract.
The role of bacteria in the urinary tract—known as the urinary
microbiome—in health and in urogenital disorders is largely
unknown. Asymptomatic bacteriuria, the presence of bacteria in
a urine specimen from a patient without signs or symptoms of
a UTI- occurs in the general population in individuals with no
known urinary tract disorder (Colgan et al., 2006). Importantly,
there is also evidence suggesting that these bacteriamaymodulate
UUI pathogenesis- at least for a subset of women. Low-count
[<105 colony forming units per milliliter (CFU/mL)] bacteria
in urine has been associated with symptoms of overactive
bladder syndrome (OAB; Sorrentino et al., 2015), including UUI
(Brubaker et al., 2014). Further, altered bacterial communities
have been identified in women with UUI in studies that have
performed EQUC and 16S rRNA gene sequencing (Hilt et al.,
2014; Pearce et al., 2014; Thomas-White et al., 2016). These
studies provide evidence that OAB symptoms, including UUI,
could be influenced by alterations in the urinary microbiome.
However, these studies had several characteristics that were
different between their UUI and control cohorts, such as age,
BMI, and hormonal status, all of which may relevantly affect the
urinary microbiota composition. Furthermore, there are only a
handful of urinary microbiome studies to date, underscoring the
great need for more research in this area.
The goal of this prospective study is to characterize the urinary
microbiome in health and in UUI, and to determine whether
differences in microbial composition and diversity are observed
between these groups. We also wanted to identify possible
relationships between symptom severity and the composition
of the urinary microbiome in women with UUI. We sampled
the urinary microbiota by amplification of the 16S rRNA
gene followed by sequencing on the Illumina MiSeq platform.
Our participants (cases with UUI and controls with normal
bladder function) are well phenotyped for bladder function with
detailed validated bladder questionnaires and attention is given
to minimize confounding variables such as menopausal and
estrogen status. Our results indicate that there is a polymicrobial
community in the female bladder in both healthy controls and
women with UUI. We identify statistically significant differences
in the relative abundance of specific bacteria in women with
UUI compared to controls. We also show that lower microbial
diversity is associated with increase symptom severity in women
with UUI. These results suggest that the urinary microbiome
may play an important role in the pathophysiology of UUI
and that the loss of diversity may be associated with clinical
severity.
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MATERIALS AND METHODS
Participants and Sample Collection
This case-control study was conducted at Oregon Health and
Science University (OHSU). The study was approved by OHSU’s
Institutional Review Board (IRB 10729) and written consent
was obtained from all participants. Participants were women
between the ages of 40 and 70 recruited from the general
public through flyers posted around OHSU’s Center forWomen’s
Health and public areas around OHSU. We recruited 10 women
with normal bladder function (controls), and 10 women with
daily UUI (cases). Control subjects included females without any
history of overactive bladder syndrome or current urge urinary
incontinence, urgency, or frequency. Case subjects included
females with daily UUI for at least the previous 3 months.
For both groups, symptom qualifications were confirmed by
medical history and 3-day bladder diary that included the
frequency of urination, leakage episodes (if any), volume of fluid
intake, and assessments of urgency through the urgency severity
scale (USS; Cartwright et al., 2011). Exclusion criteria included
history of frequent stress urinary incontinence (>once a week),
prior urinary incontinence surgery, symptomatic pelvic organ
prolapse, history of chronic pelvic pain lasting more than 3
months, history of pelvic irradiation or bladder cancer, current
urinary tract infection, antibiotic use in the previous month, and
past or present neurological diseases such as stroke, epilepsy,
multiple sclerosis, traumatic brain injury, and spinal cord injury.
All participants completed the International Consultation on
Incontinence Questionnaire (ICIQ; Avery et al., 2004), Pelvic
Floor Distress Inventory Urogenital Distress Inventory (UDI)
(Barber et al., 2005), Pelvic Floor Impact Questionnaire (PFIQ)
(Barber et al., 2005), and Overactive Bladder Questionnaire
(OABq) (Coyne et al., 2002). These are validated questionnaires
to assess urinary incontinence symptoms, impact of pelvic floor
disorders on daily function, quality of life, symptom bother and
health-related quality of life, respectively.
Urine was collected using aseptic technique with a urethral
catheter by a trained and licensed practitioner. The total volume
of urine was emptied from the participant’s bladders. After
specimen collection, urine specimens were aliquoted into sterile
50mL conical tubes and stored at−20◦Cuntil further processing.
All urine specimens were handled in a sterile biosafety cabinet
subsequent to collection.
DNA Extraction
DNA was extracted from microbial pellets formed from the
centrifugation of 25–70mL of urine at 10000 g for 30 min
twice. DNA extraction was performed using the cultured cells
protocol supplied with the DNeasy Blood and Tissue Kit (Qiagen,
Germany). The extracted DNA was quantified and quality
checked at A260/A280 nm (Nanodrop, Thermo Fisher Scientific,
USA) prior to amplification by polymerase chain reaction (PCR).
PCR Amplification
Bacterial DNA was amplified by PCR using Golay barcoded
primers which target the V4 region of 16S rRNA genes (Caporaso
et al., 2012). Template DNA was amplified in triplicate using the
GoTaq Hot Start Polymerase kit (Promega, USA). One microliter
of template DNA and 1µL of a unique barcoded reverse primer
were added to 48µL of master mix containing 1x colorless
reaction buffer, 1.5mM MgCl2, 0.2mM dNTPs, 0.2mM forward
primer, and 1.25 U of polymerase enzyme. The reaction volumes
were placed in a thermocycler and run through the following
conditions: 94◦C for 3min (initial denaturation), followed by 35
cycles of 94◦C for 45 s (denaturation); 55◦C, 40 s (annealing);
72◦C, 1.5min (extension); with a final extension at 72◦C for
10min.
PCR Product Purification and Sample
Pooling
Ten microliters of each product was used to verify amplification
by gel electrophoresis on a 2% agarose gel. Replicates yielding
visible bands at 382 bp were pooled together and purified
following theQIAquick PCRPurification kits (Qiagen, Germany)
provided protocol. Purified products were again quantified and
quality checked at A260/A280 nm (Nanodrop, Thermo Fisher
Scientific, USA). Products were diluted to 10 ng/µL and 5 µL of
each sample were pooled together for sequencing on the Illumina
MiSeq sequencer (Illumina, USA).
Sequence Processing and Taxonomic
Identification
Primers and sequence adapters were removed with the Illumina
MiSeq Reporter (version 2.5). The sequences were further
processed using scripts implemented through the workflow
package Quantitative Insights into Microbial Ecology (QIIME)
version 1.9.0 (Caporaso et al., 2010). Individual sequence reads
were joined using FASTQ-join (ea-utils, version 1.1.2-537;
Aronesty, 2013), with a maximum number of 3 mismatches
and minimum overlap of 6. Reads were demultiplexed and
filtered with the minimum acceptable Phred score of 21. Reads
were checked for alignment to the human genome (assembly
GRCh38) with BLAST (version 2.2.22). Operational taxonomic
units (OTUs) were identified with a closed-reference approach
against the Silva v119 reference database (Quast et al., 2013)
using the uSearch (version 5.2.236; Edgar, 2010) algorithm.
Chimeric sequences were removed with the blast_fragments
approach implemented in identify_chimeric_seqs.py. Taxonomy
was assigned to individual OTUs using the RDP Classifier
(version 2.2; Wang et al., 2007) with a minimum confidence
of 0.80. The resulting OTU table was imported into R for
filtering and statistical analysis. Our workflow is provided in
the Supplementary Materials (Supplementary Figure 1). The 16S
rRNA gene sequences are available for download from the Short
Read Archive (SRA) under accession number SUB1600610.
RT-qPCR to Quantify Amount of Bacterial
DNA in Urine
Bacterial DNA was amplified by RT-qPCR using the FemtoTM
Bacterial DNA Quantification Kit (Zymo Research, USA) which
contains primers that target the 16S rRNA gene. Two microliters
of template DNA, standards, and controls were individually
added to 18µL of Zymos proprietary master mix in triplicate.
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The reaction volumes were placed in a Chromo4 thermocycler
(Bio-Rad Laboratories, USA) and run through the following
conditions: 94◦C for 10 min (initial denaturation), followed by
40 cycles of 95◦C for 30 s (denaturation); 50◦C, 30 s (annealing);
72◦C, 1min (extension); with a final extension at 72◦C for 7min.
Product amplification and size were verified by running out on
a 2% agarose gel at 150 V for 30min (See Supplementary Figure
2). Amplification data was collected from the thermocycler based
on the known input values of the standard curve DNA. This raw
data was then used to calculate the total number of bacterial DNA
in femtograms present per mL of urine used for DNA extraction.
Statistical Analyses
Differences in baseline characteristics between the two groups
(cases and controls) were evaluated using t-tests for continuous
variables and the Fisher’s exact test for categorical variables. All
analyses were performed in R (v 3.2.1).
Descriptive statistics and initial visualization of the
microbiome data was performed using phyloseq (version
1.14.0, McMurdie and Holmes, 2013). Diversity measures were
calculated on the raw count data. Descriptive comparisons of the
bacterial communities were performed on relative abundances to
account for differences in the number of reads between samples.
For these analyses, low abundance OTUs making up <0.2% of
the sample’s total number of reads were removed. For stacked
barplots and hierarchical clustering, all bacterial genera that
had a mean abundance <0.5% were grouped into an “other”
category. Metatstats (White et al., 2009) was used for group
comparisons. Hierarchical clustering was performed on the
weighted Unifrac distances in R using hclust with the ward.D2
method (Ward, 1963). Pearson correlations were calculated in R
using the rcorr function in the Hmisc package (version 3.17-1).
We identified candidate OTUs with differential relative
abundance between the UUI and Control urine samples using
the DESeq2 package (version 1.8.2; Love et al., 2014) in the
R Bioconductor Framework to fit generalized linear models of
abundance based on the negative binomial distribution. The
significance of the coefficient of the fitted models was inferred
with the Wald test. To increase power, we filtered out OTUs with
zero counts in >80% of the samples, which reduces the burden
of multiple testing correction. Candidate OTUs with an FDR-
adjusted p < 0.1 were validated as being differentially abundant
between groups if the OTU was not driven by a single sample
or only present in high-read count samples (samples with total
number of reads >300,000), as evaluated by histograms of the
raw count data (data not shown).
RESULTS
All women were between the ages of 42 and 68 years. The women
in both groups were similar in BMI, history of pelvic surgery for
non-incontinence indications, menopausal status, and estrogen
treatment (Table 1). As expected, the UUI group had higher
scores on the symptom severity pelvic floor questionnaires (ICIQ,
UDI, OABq, p < 0.001), increased urgency as measured by
the percentage of voids rated with a USS score of 3 or higher
(p = 0.01) and by average USS (p = 0.05), and had lower scores
TABLE 1 | Participant demographics and symptoms.
Control UUI p-values
DEMOGRAPHICS
N 10 10 ns
Age 58 (9) 57 (8) ns
BMI (kg/m2) 28.3 (6.0) 31.2 (7.8) ns
Pelvic surgery 5 7 ns
Postmenopausal 7 8 ns




2.0 (1.2) 11.5 (4.8) < 0.001
Urinary distress inventory (UDI) 0.2 (0.6) 10.4 (5.5) < 0.001
OABq—symptom severity 6.0 (6.0) 48.3 (20.9) < 0.001
OABq—Health related quality of
life
97.7 (2.5) 66.3 (22.4) 0.002
Percent USS >= 3 10.0 (2.0) 38.5 (23.1) 0.01
Average urgency severity score
(USS)
1.6 (0.6) 2.1 (0.6) 0.05
BLADDER DIARY
Urge leaks per day 0 (0) 2.0 (1.3) 0.001
Voids per day 7.4 (2.5) 8.4 (2.2) ns
Average voids per night 0.2 (0.3) 0.5 (0.8) ns
DIET
Daily caffeine 7 7 ns
Weekly alcohol consumption 5 3 ns
Continuous variables are reported as mean (standard deviation), counts reported as the
number of individuals with the described demographic. BMI, body mass index; OABq,
Overactive Bladder Questionnaire; and USS, Urgency Severity Scale; ns, not significant
(based on p < 0.05).
on the OABq Health Related Quality of Life (HRQL p = 0.002,
see Table 1). The women in the UUI group also had a significant
greater number of leaks (p= 0.001), but not number of voids per
day (p = 0.43) or number of nighttime voids (p = 0.35) than the
control group. All urine specimens were negative for nitrites on a
urine dipstick to rule out current UTI.
Total DNA was extracted from all urine samples in order
to quantify bacterial DNA and to characterize the microbial
community of the bladder by 16S rRNA gene sequencing.
One sample had a low amount of bacterial DNA below the
detection limit of the FEMTO quantification kit. This sample
was sequenced, but had a low number of reads (∼57,000 reads),
and was predominantly composed of a known contaminant
(Deinococcus-Thermus; Salter et al., 2014). This sample was
removed from further analyses, resulting in a 95% success rate
for microbiome sequencing and characterization.
Of the remaining 19 samples (10 cases, 9 controls), the
amount of bacterial DNA varied from 31 fg/mL to 1.6 ng/mL
(median 95 fg/mL, see Figure 1A), with no difference between
cases and controls (median 101 fg/mL in case urine samples,
98 fg/mL control urine samples, p = 0.36). After preprocessing
and removing non-bacterial and low-count OTUs as described in
methods, 3,944,610 reads were classified into 456 OTUs that were
used for downstream analyses (see Supplementary Figure 1).
The average number of reads classified as bacteria from healthy
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FIGURE 1 | Distribution of bacteria in urine samples in control and UUI groups. (A) The log transformed concentrations of bacteria. (B) The number of reads
per sample after preprocessing. These reads were classified into operational taxonomic units (C) and further classified into bacterial genera (D). OTUs, operations
taxonomic units; CTL, control; UUI, urgency urinary incontinence.
control (CTL) urine was 252,611 (standard deviation 217,087)
and from UUI urine was 167,110 (standard deviation 148,606)
and was not significantly different (p= 0.34). The large standard
deviations are due to five samples (four from control samples and
one UUI sample) that had a large number of reads (>300,000)
compared to the other samples (range 57,206–190,754 reads per
sample, Figure 1B). These samples were flagged to identify if the
number of reads skewed any analyses.
Bacteria in the Bladder
We identified 456 unique OTUs, which are considered to be
representative of individual bacterial species or a closely related
group of species. The average number of OTUs per sample was
39 for controls and 49 for UUI samples (p = 0.2, Figure 1C).
We identified these OTUs as belonging to 24 different Phyla
from all urine specimens. At this level, 97% of the bacteria were
classified as either Firmicutes, Proteobacteria, Actinobacteria,
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FIGURE 2 | Microbiome diversity overview between women with normal bladder function (CTL, controls) and women with daily urgency urinary
incontinence (UUI, cases). At the phyla level (inner circle), the composition is similar with a few slight differences. At the family level (outer circle), however, some
differences are apparent such as a marked decrease in Bifodobacteriaceae and Prevotellaceae, and increase in Enterobacteriaceae and Flavobacteriaceae in UUI
compared to controls.
or Bacteroidetes. Bacteria from these four phyla were found in
most (>17) urine specimens at some level. The average relative
abundances for UUI and CTL urine are listed in Table 1 and
summarized in Figure 2. Three percent of bacteria were classified
as belonging to 16 other Phyla, which were each present only
in a subset of the urine samples [between 1 and 14 (5–74%) of
the urine samples], typically in low abundance (<16.1%). See
Supplementary Table 1 for a list of all bacteria identified from
urine specimens.
The most abundantly detected Phylum was Firmicutes
(mean OTU frequency: 48.7% UUI, 42.8% CTL), followed
by Proteobacteria (mean OTU frequency: 25.0% UUI, 15.9%
CTL), Actinobacteria (mean abundance: 11.6% UUI, 19.3%
CTL), and Bacteroidetes (mean abundance: 8.7% UUI,
17.6% CTL). The most abundant bacterial families with
mean abundances >2% were Bacillaceae, Lactobacillaceae,
and Lachnospiraceae (Firmicutes phylum); Prevotellaceae and
Flavobacteriacea (Bacteroidetes phylum); Bifidobacteriaceae, and
Micrococcaceae (Actinobacteria phylum); Enterobacteriaceae
and Comamonadaceae (Proteobacteria phylum, see
Table 2, Figure 2). At the genus level, 7 genera had mean
abundances >2%. These include Prevotella (Bacteroidetes
phylum); Gardnerella and Arthrobacter (Actinobacteria
phylum); Escherichia-Shigella (Proteobacteria phylum); and
Anoxybacillus, Lactobacillus, and unknown (Firmicutes
phylum).
The phyla Firmicutes and Actinobacteria were present in
all urine specimens, and Proteobacteria and Bacteroidetes were
found in all but one urine specimen. No families were found
in all samples. Twenty bacterial families were found in at least
half of the samples. Forty-seven percent of bacterial families were
identified in both the UUI and CTL urine, 19% families were
only identified in control urine, and 34% different families were
TABLE 2 | Mean relative abundance of bacteria (as percent) in UUI and
control urine; reported by Phyla: Family.
Case (%) Control (%) p-values
Firmicutes 48.7 42.7 0.60
Bacillaceae 20.3 17.4 0.57
Lactobacillaceae 19.6 19.0 0.98
Lachnospiraceae 2.4 < 2.0 0.69
Proteobacteria 25.0 15.9 0.16
Enterobacteriaceae 6.9 2.5 0.26
Comamonadaceae 5.9 2.3 0.08
Actinobacteria 11.6 19.3 0.40
Micrococcaceae 5.9 7.0 0.60
Bifidobacteriaceae < 2.0 9.4 0.51
Bacteroidetes 8.4 17.6 0.30
Prevotellaceae 3.1 14.2 0.20
Flavobacteriaceae 2.2 < 2.0 0.35
only identified in UUI urine (Figure 3A). Forty-one percent of
the bacterial genera were found in both UUI and CTL urine.
Thirty-seven percent genera were only present in UUI urine (4
were present in 3 samples, 8 were present in 2 samples, and the
remainder were only present in one sample). Twenty-two percent
of genera were only identified in CTL urine (5 were present in
two samples, the remainder only present in one sample), see
Figure 3B.
Differentially Abundant OTUs
We identified 24 candidate OTUs that are significantly
differentially abundant between CTL and UUI groups as
described in the methods. Of the candidate OTUs, 14 were
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FIGURE 3 | A Venn diagram depicting the number of bacterial families (A) and genera (B) that are shared and unique between CTL and UUI urine.
verified. Nine OTUs were more abundant and five OTUs
were less abundant in UUI compared to controls (Figure 4).
Most of the OTUs were classified at the genus level (9),
two at the family level and one at the order level. Five of
these bacteria (Alteromonadaceae spp.; Krishna et al., 2011),
Stenotrophomonas spp. (Moore et al., 1997; Kumar et al., 2015),
Brevundimonas spp. (Han and Andrade, 2005), Elizabethkingia
spp. (Zong, 2014; Hagiya et al., 2015), andMethylobacterium spp.
(Lee et al., 2004) that are increased in UUI have been associated
previously with urinary tract infections.
Individual Variability
The composition of each individual’s urinary microbiome varied
greatly, with anywhere from 2 to 49 different bacterial families
detected per sample (Figure 5). Four controls and two cases
had a microbiota that was dominated by a single bacterial
genus (a genus dominating at least 45% of the microbiome
sample, as defined by Pearce et al.), while all other samples
were diverse. The dominating bacterial genera were Gardnerella
(one control), Lactobacillus (one control and two cases), and
Prevotella (two controls). The four samples dominated by
Lactobacillus and Gardnerella were all from premenopausal
women. The number of different bacterial genera in each
individual’s urinary microbiome ranged from 2 to 59 (cases range
2–59 genera per sample, control range 10–42 genera per sample,
Figure 1D).
Hierarchical clustering divided the samples into 4 main
groups (Figure 5). The clustering appears to be driven by the
diversity of bacterial families. Cluster 1 in Figure 5 is composed
of samples with 25–36 different bacterial families (mean 30.9),
and contains both CTL and UUI samples (5 CTL and 3 UUI
samples). Cluster 2 in Figure 5 contains diverse profiles with 26
to 49 different families (mean 37.3) with no dominating bacterial
family, and is composed of 6 UUI and only one CTL sample. One
sample does not belong to any clusters and is dominated by one
bacterial family. Cluster 3 is composed of three CTL samples that
are composed of 9–29 families (mean 14.7).
Diversity of Urinary Microbiome
We did not detect any significant differences in alpha diversity
measures that are established measures of species richness
and distribution within a sample [as measured by the Chao1,
Shannon Index, or Inverse Simpson index between control
and UUI specimens (Table 3)]. We noticed a great deal of
individual variability with the diversity and richness from each
sample (Supplementary Figure 3), indicating that the urine
microbiome composition not only varies in the type of bacteria
that are present but also in the number of different bacteria and
abundance of these bacteria.
Urinary Microbiome and Clinical Symptoms
Both increasing UDI score (a measure of symptom distress
of urinary incontinence) and percent of urgency incontinence
episodes (percent of voids where USS = 4) were significantly
associated with decreased measures of alpha diversity, as
observed for Inverse Simpson index (UDI, r = −0.70, p = 0.02)
and Shannon Index (percent incontinent episodes, r = −0.65,
p= 0.04), respectively. Additionally, the OABq-symptom bother
score, where a lower score is indicative of lower quality of
life due to OAB symptoms, was positively correlated with both
the Shannon and Inverse Simpson indices (Figure 6: r = 0.66,
p = 0.02 and r = 0.71, p = 0.04, respectively). None of the
symptom severity measures where significantly associated with
the Chao1 estimator of alpha diversity.
DISCUSSION
In this prospective pilot study designed to study the urinary
microbiome in a clinically well characterized patient population,
we have characterized the urinary microbiome of women
with normal bladder function and women with UUI
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FIGURE 4 | Differentially abundant bacteria in women with UUI relative to controls. Many of these bacteria were identified at the genus level. Nine bacteria
were increased and five were decreased in women with UUI compared to controls. Of the increased bacteria, five have previously been implicated in UTI (highlighted in
bold font). *FDR adjusted p < 0.1, **FDR-adjusted p < 0.05.
using high throughput Illumina MiSeq sequencing of the
bacterial 16S rRNA gene. Our results demonstrate important
similarities and differences among control and UUI urinary
microbiomes.
Bacteria in Urine
Our ability to detect bacteria from almost all of our samples is
consistent with the findings of Siddiqui et al. (2011), Siddiqui
et al. (2012), and Nelson et al. (2010); but is inconsistent
with the findings of Pearce et al. (2014), Pearce et al. (2015),
Thomas-White et al. (2016), and Wolfe et al. (2012) who
consistently identified bacteria in only about half of the urine
specimens collected. This difference could be due to sampling.
Our protocol used a minimum volume of 30mL of urine
obtained directly from the bladder through a transurethral
catheter, as did the Siddiqui and Nelson protocols. The Pearce
et al. and Wolfe et al. protocols used small volumes (1–
2mL) of similarly collected urine. Since urine typically has a
low abundance of bacteria, there may be more success with
bacterial extraction for amplification from larger volumes of
urine as used here. Other relevant considerations may be the
high salt content of urine (which may inhibit PCR reactions),
presence of large amounts of non-target DNA (e.g., humanDNA)
and potential contamination by environmental 16S rRNA gene
sequences.
Since the exploration of the urinary microbiome is still in
its infancy, there are currently no standardized protocols for
the collection and extraction of bacterial DNA from urine.
Experiments identifying ideal protocols for optimal bacterial
extraction would prove valuable to the field, especially for
the clinical utility of the urinary microbiome in a clinical
setting. Pearce et al’s recent work investigating the role of
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 8 July 2016 | Volume 6 | Article 78
Karstens et al. Urinary Microbiome in Urgency Urinary Incontinence
FIGURE 5 | Clustering of participants based on urinary microbiome profiles. The dendrogram (upper) is based on hierarchical clustering of the weighted
Unifrac distances between the bacteria found in urine samples from controls (C) and women with UUI (U). The dashed line indicates where the clades were divided
into three clusters: Cluster 1 which is comprised of five controls and three cases; Cluster 2 which is predominantly cases (six cases, one control), and Cluster 3 which
is only controls. The sample type is indicated by the rectangle below the cluster bar: U, case; C, control. One case sample did not fall into a cluster at this level. The
stacked bar plots below the heatmap represent the relative abundance of the bacterial families identified by 16S sequences present in each urine specimen. Bacterial
families with an overall mean abundance <0.5%, are grouped as “Other.” The main color is indicative of the bacterial phyla with the shade indicative of bacteria family.
TABLE 3 | Richness and diversity measures for control and UUI urinary microbiomes.
Controls UUI p-values
Measure Mean SD Min Max Mean SD Min Max
Chao1 304.7 77.6 200.2 468.6 304.9 70.1 202.5 423.1 0.995
Shannon 2.6 0.8 1.5 3.5 3.0 1.0 0.5 4.0 0.310
Inverse simpson 8.4 6.9 1.9 22.3 1.1 13.5 1.2 24.3 0.160
SD, standard deviation; Min, minimum; Max, maximum.
the urinary microbiome in UUI has identified a relationship
between the presence of urinary bacteria with a positive response
to treatment and decreased risk of UTI (Pearce et al., 2015),
and Thomas-White et al has shown a relationship between
the urinary microbiota and treatment response (Thomas-White
et al., 2016), demonstrating the potential clinical significance
of the urinary microbiome. It is important for researchers to
consider the sampling methods when interpreting these results
and in attempting to validate or replicate these findings. Due
to their low sampling volumes, it is possible their “sequence
negative” samples are specimens with a low bacterial load which
may be sequence positive if a larger volume of urine was
used.
Types of Bacteria in Urine
Our analysis revealed that human female urine has a
polymicrobial composition and that there is substantial
variation between urine samples from different individuals.
All urine specimens were predominantly composed of bacteria
from four phyla: Firmicutes, Bacteroidetes, Proteobacteria, and
Actinobacteria, which were also present in most urine specimens
to some degree. Firmicutes was the most abundant Phyla,
consistent with the findings of Siddiqui and Pearce (Siddiqui
et al., 2011, 2012; Pearce et al., 2014, 2015).
Some bacteria present in the urinary microbiome are
commonly found in the vaginal microbiome, such as
Lactobacillus. These are likely not contamination due to
our collection of specimens with a transurethral catheter inserted
by an experienced provider using sterile technique. Additional
evidence against these being contaminants comes from Wolfe
et al. who detected these bacteria from urine specimens collected
through suprapubic aspirates (Wolfe et al., 2012).
We noticed a great deal of individual variability with the
diversity and richness from each sample, indicating that the
urine microbiome composition not only varies in the type of
bacteria that are present but also in the number of different
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FIGURE 6 | Increasing UUI symptom severity is associated with decreased microbial diversity in women with UUI. We identified relationships between the
richness and evenness of the urinary microbiome (as measured by the Inverse Simpson and Shannon indices, where lower scores are indicative of lower microbial
diversity) and UUI symptom severity. The percent of incontinent episodes is measured by percent of voids with an USS score equal to 4 on a 3 day bladder dairy, and
an increase indicates more incontinent episodes. The urogenital distress inventory is a validated questionnaire measuring symptom distress from incontinence and a
higher score indicates more distress. Both of these measures have a significant negative correlation with microbial diversity. The OABq-symptom bother is the health
related quality of life score from the validated overactive bladder questionnaire. A higher score indicates less symptom bother and is positively correlated with diversity
measures. Together, these data indicate that a reduction in microbial diversity is associated with an increase in symptom severity.
bacteria and relative abundance of these bacteria. In our study,
only 26% (5 out of 19) samples demonstrated a dominant
bacterial genera: one Gardnerella, two Prevotella, and three
Lactobacillus. This is different than the findings of the studies
by Pearce et al. and Thomas-White (Pearce et al., 2014, 2015;
Thomas-White et al., 2016) where they found the majority of
their specimens to be dominated by a single genera (>45% of
sequences per sample), typically Lactobacillus and Gardnerella.
This difference could be due to our small number of participants
in our sample, differences in participant populations (our cohort
was composed primarily of post-menopausal women that were
not using estrogen therapy), differences in urine sample volumes,
or preprocessing/filtering techniques used on the data. The
three samples that were dominated by the lactic acid producing
Lactobacillus were from three out of five pre/perimenopausal
women in our cohort. While our sample size is too small for
statistical analysis of this finding, it suggests that the urinary
microbiome may drastically change after menopause, as is a well-
known phenomenon that occurs with the vaginal microbiome
(Brotman et al., 2014). These findings suggest that one underlying
driver for a shift in urinary microbiome, and hence development
of abnormal urinary symptoms and poor urinary control
associated with overactive bladder, may be changes in hormonal
status associated with menopause.
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The Urinary Microbiome in UUI
We identified fourteen bacteria with significant differential
relative abundances between UUI urine and control urine. Of
the nine bacteria that had increased relative abundance in UUI
urine, five of these bacteria have been reported as pathogens
causing UTI. This suggests that a persistent low grade infection
by bacteria that are not commonly detected by routine cultures
could potentially be responsible for the irritative symptoms of
UUI, at least for some individuals.
We did not detect any differences in the diversity or richness
measures between control and UUI specimens. This is consistent
with Pearce et al.’s findings, and our diversity estimates were
within the range of theirs (Pearce et al., 2014). There was
a great deal of individual variability with the diversity and
richness from each sample. The high level of individual variability
emphasizes the need to look at much larger cohorts to detect
group differences.
We also identified significant correlations with symptom
severity and alpha diversity measures in women with UUI.
Individuals with a lower species diversity had higher scores on the
UDI and higher percentage of incontinent episodes. There was
also a positive correlation with diversity indices and the OABq-
symptom bother questionnaire, where a lower score is indicative
of lower quality of life due to OAB symptoms. These data indicate
that women with more severe UUI symptoms have a decrease in
microbial diversity in their urinary microbiomes.
While our results need to be validated in a larger study, they
provide evidence that the diversity of the urinary microbiome
may have clinical relevance. Changes in microbial diversity has
been linked to disease. In urinary tract disorders, decreased
diversity of the urinary microbiome has been linked to in
interstitial cystitis (Siddiqui et al., 2012). Urinary microbiome
diversity has been associated with response to solifenacin—an
orally administered anticholinergic medication used to treat UUI
(Thomas-White et al., 2016). Thomas-White found that a lower
diversity of cultivatable bacteria was associated with response to
low dose of solifenacin and women requiring higher doses or
non-responders to have increased diversity of cultivable bacteria,
though they did not find this association with the diversity of
sequenced microbiota. Decreased microbial diversity of other
body sites has also been associated with a variety of clinical
conditions such as obesity (Turnbaugh et al., 2009), irritable
bowel syndrome (Carroll et al., 2012), and inflammatory bowel
disease (Ott et al., 2004).
Pearce et al. also identified bacteria that were associated
with UUI (Pearce et al., 2014). They detected an increase
in Gardnerella and decrease in Lactobacillus in their UUI
population. While we did not detect these differences in
Gardnerella or Lactobacillus in our study, an important
difference between our study and Pearce et al’s study (Pearce et al.,
2014) is that our case and control groups were well balanced
with respect to menopausal status and estrogen use, where their
study had a significantly larger proportion of women in the
control group that were “estrogen positive” (premenopausal or
on estrogen treatment) than their UUI group. They also detected
nine bacteria that were more frequently sequenced or cultured
from the UUI cohort using expanded culture techniques. We
identified most of these bacteria with an even frequency between
controls and cases, and did not detect Oligella, Actinobaculum,
or Actinomycyes above our threshold of 0.2% of sequence reads
in any of our samples.
CONCLUDING REMARKS
These findings have the potential to transform our understanding
of the pathogenesis of UUI and other disorders of the bladder.
With a larger clinically well-characterized cohort and with
the appropriate diagnostic and analytic tools, we may be well
positioned to identify a subset of patients with UUI for whom
the diversity, presence, or absence of certain bacteria may play
a key role in the pathophysiology of their disease. With careful
phenotyping of patients and understanding of heterogeneous
pathophysiology, it will be possible to identify those patients for
whom targeted therapy through restoration of normal urinary
microbiome may restore normal bladder function.
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